These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8419152)

  • 1. Japanese guidelines for mutagenicity testing. Ministry of Agriculture, Forestry and Fisheries; Ministry of Health and Welfare; Ministry of Labor.
    Sofuni T
    Environ Mol Mutagen; 1993; 21(1):2-7; discussion 46-57. PubMed ID: 8419152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic toxicology testing requirements: official and unofficial views from Europe.
    Kirkland DJ
    Environ Mol Mutagen; 1993; 21(1):8-14; discussion 46-57. PubMed ID: 8419157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Assessment of Mutagenicity. Health Protection Branch Mutagenicity Guidelines. Health Protection Branch Genotoxicity Committee, Department of National Health and Welfare, Canada.
    Environ Mol Mutagen; 1993; 21(1):15-37; discussion 46-57. PubMed ID: 8419151
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory requirement for three dose levels in rodent genetic toxicity assays.
    Galloway S
    Mutat Res; 1995 Jul; 329(2):213-9. PubMed ID: 7603503
    [No Abstract]   [Full Text] [Related]  

  • 5. International Workshop on Standardisation of Genotoxicity Test Procedures. Report of in vivo subgroup.
    Tice RR; Shelby MD
    Mutat Res; 1994 Jun; 312(3):287-92. PubMed ID: 7514740
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenicity test schemes and guidelines: U.S. EPA Office of Pollution Prevention and Toxics and Office of Pesticide Programs.
    Auletta AE; Dearfield KL; Cimino MC
    Environ Mol Mutagen; 1993; 21(1):38-45; discussion 46-57. PubMed ID: 8419153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity tests for new chemicals in Germany: routine in vitro test systems.
    Broschinski L; Madle S; Hensel C
    Mutat Res; 1998 Oct; 418(2-3):121-9. PubMed ID: 9757015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus).
    Galloway S; Lorge E; Aardema MJ; Eastmond D; Fellows M; Heflich R; Kirkland D; Levy DD; Lynch AM; Marzin D; Morita T; Schuler M; Speit G
    Mutat Res; 2011 Aug; 723(2):77-83. PubMed ID: 21255675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of the genotoxicity of Eriobotrya japonica leaf extract.
    Jeong MH; Seong NW; Lee JY; Kim YJ; Shin NR; Kim JC
    Regul Toxicol Pharmacol; 2018 Nov; 99():238-243. PubMed ID: 30268829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity studies of 2,6-dinitrotoluene (2,6-DNT).
    Suzuki H; Imamura T; Koeda A; Morimoto K; Wakasa Y; Takei Y; Amemiya R; Hatakeyama H; Satoh H; Sato S
    J Toxicol Sci; 2011 Aug; 36(4):499-505. PubMed ID: 21804315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry.
    Purves D; Harvey C; Tweats D; Lumley CE
    Mutagenesis; 1995 Jul; 10(4):297-312. PubMed ID: 7476265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Series: 'Current issues in mutagenesis and carcinogenesis.' No. 42. Strategies and philosophies of genotoxicity testing: what is the question?
    Zeiger E
    Mutat Res; 1994 Jan; 304(2):309-14. PubMed ID: 7506375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An industrial and UK perspective on short-term testing.
    Gatehouse DG
    Prog Clin Biol Res; 1990; 340D():249-59. PubMed ID: 2371298
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of in vitro cytogenetic techniques in nine European laboratories in relation to chromosomal endpoints induced by three model mutagens.
    Sorsa M; Autio K; Abbondandolo A; Carbonell E; Demopoulos N; Garner C; Kirsch-Volders M; Marcos R; Marafante E; Natarajan AT
    Mutat Res; 1992 Jun; 271(3):261-7. PubMed ID: 1378199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Introduction of the "Positive List" system for agricultural chemicals in foods and development of analytical methods --recent amendment of regulation on pesticides by the Ministry of Health, Labour and Welfare, the Ministry of Agriculture, Forestry and Fisheries, and the Ministry of the Environment].
    Maitani T
    Shokuhin Eiseigaku Zasshi; 2005 Dec; 46(6):J327-34. PubMed ID: 16440798
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with mutagenicity testing of new drugs: viewpoint of a regulatory agency.
    Madle S; Korte A; Bass R
    Mutat Res; 1987 Aug; 182(4):187-92. PubMed ID: 3302693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
    Jacobson-Kram D; Contrera JF
    Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Japanese mutagenicity studies guidelines for pesticide registration.
    Shirasu Y
    Mutat Res; 1988; 205(1-4):393-5. PubMed ID: 3367923
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mutagenicity studies of lactitol (NS-4)].
    Iwakura K; Tamura H; Watanabe M; Sumi N
    J Toxicol Sci; 1994 Nov; 19 Suppl 3():487-97. PubMed ID: 7837301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.